Flow Cytometric Monitoring of Residual Disease in Acute Leukemia
Author:
- 7 March 2013
- book chapter
- Published by Springer Nature
- Vol. 999, 123-136
Abstract
Multiparameter flow cytometry offers the unique ability to simultaneously assess and correlate multiple cellular properties at the single cell level in a timely and efficient manner. Application of this technique to the detection of residual acute leukemia after therapy has been shown to be of singular importance to monitor response to therapy and provide prognostic information. Principles and methods that allow for the sensitive detection of acute leukemia following therapy are presented. The basic protocol outlines a simple and efficient method for the labeling of white cells with monoclonal antibodies directed against cell surface antigens. A second method describes a general method for the simultaneous assessment of surface and cytoplasmic antigens using a combination of fixation followed by membrane permeabilization. An illustrative panel of validated reagents currently in use for residual disease detection for acute lymphoblastic leukemia of B or T cell lineage as well as acute myeloid leukemia is provided. Principles of data analysis that allow for the reproducible detection of small populations of abnormal hematopoietic cells in peripheral blood and bone marrow are presented.Keywords
This publication has 23 references indexed in Scilit:
- New markers for minimal residual disease detection in acute lymphoblastic leukemiaBlood, 2011
- The use of receiver operating characteristic analysis for detection of minimal residual disease using five‐color multiparameter flow cytometry in acute myeloid leukemia identifies patients with high risk of relapseCytometry Part B: Clinical Cytometry, 2008
- Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group studyBlood, 2008
- Incidence, Sensitivity, and Specificity of Leukemia-Associated Phenotypes in Acute Myeloid Leukemia Using Specific Five-Color Multiparameter Flow CytometryAmerican Journal of Clinical Pathology, 2008
- Prednisone induces immunophenotypic modulation of CD10 and CD34 in nonapoptotic B‐cell precursor acute lymphoblastic leukemia cellsCytometry Part B: Clinical Cytometry, 2008
- Interactions between mouse IgG2 antibodies are common and mediated by plasma C1qCytometry Part B: Clinical Cytometry, 2006
- Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemiaBlood, 2006
- Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoringCytometry Part B: Clinical Cytometry, 2004
- Minimal residual disease monitoring by flow cytometryBest Practice & Research Clinical Haematology, 2003
- High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)Blood, 2001